Global Anti-Obesity Drugs Market Research Report 2018 by Manufacturers, Regions, Types and Applications

Table of Contents

1 Report Overview

• 1.1 Definition
• 1.2 Manufacturers and Regions Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
• 1.3 Type Overview
• 1.4 Application Overview
• 1.5 Industrial Chain
  • 1.5.1 Anti-Obesity Drugs Overall Industrial Chain
  • 1.5.2 Upstream
  • 1.5.3 Downstream
  • 1.5.4 Economic/Political Environment

2 Global Anti-Obesity Drugs Market Assesment by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Anti-Obesity Drugs Market Performance
• 2.3 USA Anti-Obesity Drugs Market Performance
• 2.4 Europe Anti-Obesity Drugs Market Performance
• 2.5 Japan Anti-Obesity Drugs Market Performance
• 2.6 Korea Anti-Obesity Drugs Market Performance
• 2.7 India Anti-Obesity Drugs Market Performance
• 2.8 Southeast Asia Anti-Obesity Drugs Market Performance
• 2.9 South America Anti-Obesity Drugs Market Performance

3 Global Anti-Obesity Drugs Market Assesment by Application

• 3.1 Overall Market Performance (Volume)
• 3.2 China Anti-Obesity Drugs Market Performance (Volume)
• 3.3 USA Anti-Obesity Drugs Market Performance (Volume)
• 3.4 Europe Anti-Obesity Drugs Market Performance (Volume)
• 3.5 Japan Anti-Obesity Drugs Market Performance (Volume)
• 3.6 Korea Anti-Obesity Drugs Market Performance (Volume)
• 3.7 India Anti-Obesity Drugs Market Performance (Volume)
• 3.8 Southeast Asia Anti-Obesity Drugs Market Performance (Volume)
• 3.9 South America Anti-Obesity Drugs Market Performance (Volume)

4 Competitive Analysis

• 4.1 Pfizer
  • 4.1.1 Pfizer Profiles
  • 4.1.2 Pfizer Product Information
  • 4.1.3 Pfizer Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.1.4 Pfizer Anti-Obesity Drugs Business Performance
  • 4.1.5 SWOT Analysis
• 4.2 Merck
  • 4.2.1 Merck Profiles
  • 4.2.2 Merck Product Information
  • 4.2.3 Merck Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.2.4 Merck Anti-Obesity Drugs Business Performance
  • 4.2.5 SWOT Analysis
• 4.3 F.Hoffmann-La Roche
  • 4.3.1 F.Hoffmann-La Roche Profiles
  • 4.3.2 F.Hoffmann-La Roche Product Information
  • 4.3.3 F.Hoffmann-La Roche Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.3.4 F.Hoffmann-La Roche Anti-Obesity Drugs Business Performance
  • 4.3.5 SWOT Analysis
• 4.4 GlaxoSmithKline
  • 4.4.1 GlaxoSmithKline Profiles
  • 4.4.2 GlaxoSmithKline Product Information
  • 4.4.3 GlaxoSmithKline Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.4.4 GlaxoSmithKline Anti-Obesity Drugs Business Performance
  • 4.4.5 SWOT Analysis
• 4.5 AstraZeneca
  • 4.5.1 AstraZeneca Profiles
  • 4.5.2 AstraZeneca Product Information
  • 4.5.3 AstraZeneca Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.5.4 AstraZeneca Anti-Obesity Drugs Business Performance
  • 4.5.5 SWOT Analysis
• 4.6 Boehringer Ingelheim
  • 4.6.1 Boehringer Ingelheim Profiles
  • 4.6.2 Boehringer Ingelheim Product Information
  • 4.6.3 Boehringer Ingelheim Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.6.4 Boehringer Ingelheim Anti-Obesity Drugs Business Performance
  • 4.6.5 SWOT Analysis
• 4.7 Novo Nordisk
  • 4.7.1 Novo Nordisk Profiles
  • 4.7.2 Novo Nordisk Product Information
  • 4.7.3 Novo Nordisk Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.7.4 Novo Nordisk Anti-Obesity Drugs Business Performance
  • 4.7.5 SWOT Analysis
• 4.8 Eisai
  • 4.8.1 Eisai Profiles
  • 4.8.2 Eisai Product Information
  • 4.8.3 Eisai Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.8.4 Eisai Anti-Obesity Drugs Business Performance
  • 4.8.5 SWOT Analysis
• 4.9 Norgine
  • 4.9.1 Norgine Profiles
  • 4.9.2 Norgine Product Information
  • 4.9.3 Norgine Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.9.4 Norgine Anti-Obesity Drugs Business Performance
  • 4.9.5 SWOT Analysis
• 4.10 Arena Pharmaceuticals
  • 4.10.1 Arena Pharmaceuticals Profiles
  • 4.10.2 Arena Pharmaceuticals Product Information
  • 4.10.3 Arena Pharmaceuticals Anti-Obesity Drugs Production, Revenue, Price and Gross Margin
  • 4.10.4 Arena Pharmaceuticals Anti-Obesity Drugs Business Performance
  • 4.10.5 SWOT Analysis
• 4.11 Orexigen Therapeutics
• 4.12 Vivus
• 4.13 Alizyme
• 4.14 Rhythm Pharmaceuticals
• 4.15 Shionogi
• 4.16 Zafgan

5 Competitive Landscape

• 5.1 Global Anti-Obesity Drugs Production (K Units) and Market Share by Manufacturers (2014-2020)
• 5.2 Global Anti-Obesity Drugs Revenue (M USD) and Market Share by Manufacturers (2014-2020)
• 5.3 Global Anti-Obesity Drugs Price (USD/Unit) of Manufacturers (2014-2020)
• 5.4 Global Anti-Obesity Drugs Gross Margin of Manufacturers (2014-2020)
• 5.5 Market Concentration

6 Global Anti-Obesity Drugs Market Assessment by Regions

• 6.1 Global Anti-Obesity Drugs Production (K Units) and Market Share by Regions (2014-2020)
• 6.2 Global Anti-Obesity Drugs Revenue (M USD) and Market Share by Regions (2014-2020)
• 6.3 Global Anti-Obesity Drugs Price (USD/Unit) by Regions (2014-2020)
• 6.4 Global Anti-Obesity Drugs Gross Margin by Regions (2014-2020)

7 Anti-Obesity Drugs Regional Analysis

• 7.1 China Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.2 USA Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.3 Europe Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.4 Japan Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.5 Korea Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.6 India Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.7 Southeast Asia Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)
• 7.8 South America Anti-Obesity Drugs Production, Revenue and Growth Rate (2014-2020)

8 Global Anti-Obesity Drugs Consumption Assessment

• 8.1 Global Anti-Obesity Drugs Consumption and Market Share by Regions (2014-2020)
• 8.2 Global Anti-Obesity Drugs Consumption Value and Market Share by Regions (2014-2020)
• 8.3 Global Anti-Obesity Drugs Average Price (USD/Unit) by Regions (2014-2020)

9 Global Anti-Obesity Drugs Sales Assessment by Regions

• 9.1 Global Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.2 China Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.3 USA Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.4 Europe Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.5 Japan Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.6 Korea Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.7 India Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.8 Southeast Asia Anti-Obesity Drugs Sales and Sales Value (2014-2020)
• 9.9 South America Anti-Obesity Drugs Sales and Sales Value (2014-2020)

10 Technology and Cost

• 10.1 Technology
• 10.2 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Market Forecast 2021-2026

• 12.1 Production and Revenue Forecast 2021-2026
  • 12.1.1 Global Anti-Obesity Drugs Production and Revenue by Regions 2021-2026
  • 12.1.2 China Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.3 USA Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.4 Europe Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.5 Japan Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.6 Korea Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.7 India Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.8 Southeast Asia Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
  • 12.1.9 South America Anti-Obesity Drugs Production, Revenue and Growth Rate 2021-2026
• 12.2 Sales and Sales Value Forecast 2021-2026
  • 12.2.1 Global Anti-Obesity Drugs Consumption and Consumption Calue by Regions 2021-2026
  • 12.2.2 Global Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.3 China Anti-Obesity Drugs Sales, Sales Value and Growth Rate 2021-2026
  • 12.2.4 USA Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.5 Europe Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.6 Japan Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.7 Korea Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.8 India Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.9 Southeast Asia Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
  • 12.2.10 South America Anti-Obesity Drugs Sales and Sales Value Forecast 2021-2026
• 12.3 Global Anti-Obesity Drugs Production and Revenue Forecast by Type 2021-2026
  • 12.3.1 Overall Market Performance
  • 12.3.2 Prescription Drugs
  • 12.3.3 OTC drugs
• 12.4 Global Anti-Obesity Drugs Sales Forecast by Application 2021-2026
  • 12.4.1 Overall Market Performance
  • 12.4.2 6-18 Callant
  • 12.4.3 18-30 Adult
  • 12.4.4 30-60Middle-Aged
  • 12.4.5 Others
• 12.5 Global Anti-Obesity Drugs Price and Gross Margin Forecast
  • 13.5.1 Global Anti-Obesity Drugs Averages Price Development Trend Forecast 2021-2026
  • 13.5.2 Global Anti-Obesity Drugs Gross Margin Development Trend Forecast 2021-2026

13 Conclusion